Profil
Mr. Joseph Theuns, CFA, is an Insurance Associate at Bernstein Autonomous LLP.
He joined the firm in 2022, to help cover the European Insurance sector.
Prior to this, Mr. Theuns spent four years at Cambridge Associates, where he advised institutional clients on asset allocation and investment strategy.
He holds an MSc in Accounting & Finance from the London School of Economics as well as a BSc in Investment and Financial Risk Management from Bayes (formerly Cass) Business School.
He is a CFA charterholder.
Aktive Positionen von Joseph Theuns
| Unternehmen | Position | Beginn |
|---|---|---|
Bernstein Autonomous LLP
 Bernstein Autonomous LLP Investment ManagersFinance Bernstein Autonomous LLP (dba Autonomous Research) is an investment research firm headquartered in London, UK. The firm was founded in 2009 and is a subsidiary of Sanford C. Bernstein (Autonomous UK) 1 Ltd., ultimately owned by Equitable Holdings, Inc. (NYSE: EQH) in the US. Autonomous Research provides fundamental analysis and thematic work on financial companies globally. Their clients are large institutional investors along with private equity firms, regulators, financial advisors and corporations who value the firm's research for its in-depth, intellectual approach and high quality. | Analyst-Equity | 01.10.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Bernstein Autonomous LLP
Bernstein Autonomous LLP Investment ManagersFinance Bernstein Autonomous LLP (dba Autonomous Research) is an investment research firm headquartered in London, UK. The firm was founded in 2009 and is a subsidiary of Sanford C. Bernstein (Autonomous UK) 1 Ltd., ultimately owned by Equitable Holdings, Inc. (NYSE: EQH) in the US. Autonomous Research provides fundamental analysis and thematic work on financial companies globally. Their clients are large institutional investors along with private equity firms, regulators, financial advisors and corporations who value the firm's research for its in-depth, intellectual approach and high quality. | Finance |
